3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
fludarabine
10
ruxolitinib
9
fludarabine phosphate
9
Whole-Body Irradiation
9
Specimen Handling
9
Cyclophosphamide
8
Azacitidine
8
Mycophenolic Acid
7
Cytarabine
7
Busulfan
7
Biopsy
7
Tacrolimus
6
venetoclax
5
Stem Cell Transplantation
5
Sirolimus
5
Peripheral Blood Stem Cell Transplantation
5
Injections
5
Granulocyte Colony-Stimulating Factor
5
Melphalan
4
Cyclosporine
4
CPX-351
4
luspatercept
3
ivosidenib
3
decitabine and cedazuridine drug combination
3
Thiotepa
3
Methotrexate
3
Liposomes
3
Idarubicin
3
Daunorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
2C4 antibody
×
90 days
×
Clear all
No trials found.